Bloomberg News

Mela Sciences Shares Surge After FDA Approves Cancer Test

November 02, 2011

Nov. 2 (Bloomberg) -- Mela Sciences Inc., the maker of the MelaFind melanoma-detection device, gained 19 percent after receiving Food and Drug Administration approval to sell the product in the U.S.

Mela rose to $6.42 at 8:10 a.m. The Irvington, New York- based company said in a statement today that it plans to first introduce the test in the northeastern U.S. in 2012.

--Editor: Chris Staiti

To contact the reporter on this story: Bruce Rule in New York at brule1@bloomberg.net

To contact the editor responsible for this story: Reg Gale at Rgale5@bloomberg.net


Cash Is for Losers
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus